BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 11075296)

  • 1. Early β-hCG levels predict live birth after single embryo transfer.
    Hughes LM; Schuler A; Sharmuk M; Schauer JM; Pavone ME; Bernardi LA
    J Assist Reprod Genet; 2022 Oct; 39(10):2355-2364. PubMed ID: 36074224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial.
    Zarei A; Parsanezhad ME; Younesi M; Alborzi S; Zolghadri J; Samsami A; Amooee S; Aramesh S
    Iran J Reprod Med; 2014 Jan; 12(1):1-6. PubMed ID: 24799855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer.
    Reljič M; Knez J; Vlaisavljević V
    J Assist Reprod Genet; 2013 Nov; 30(11):1459-63. PubMed ID: 24043384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.
    Hsu MI; Kolm P; Leete J; Dong KW; Muasher S; Oehninger S
    J Assist Reprod Genet; 1998 Sep; 15(8):496-503. PubMed ID: 9785197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S; Polyzos NP; Haentjens P; Smitz J; Camus M; Tournaye H; Blockeel C
    Hum Reprod; 2014 Aug; 29(8):1698-705. PubMed ID: 24939956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superovulation with human chorionic gonadotropin (hCG) trigger and gonadotropin releasing hormone agonist (GnRHa) trigger differentially alter essential angiogenic factors in the endometrium in a mouse ART model†.
    Segal TR; Amini P; Wang J; Peters G; Skomorovska-Prokvolit Y; Mainigi MA; Goldfarb JM; Mesiano S; Weinerman R
    Biol Reprod; 2020 Apr; 102(5):1122-1133. PubMed ID: 31995151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin levels in successful implantations after assisted reproduction techniques.
    Ertzeid G; Tanbo T; Dale PO; Storeng R; Mørkrid L; Abyholm T
    Gynecol Endocrinol; 2000 Aug; 14(4):258-63. PubMed ID: 11075296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
    Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
    Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.